VERU INC. Line of Credit Facility, Maximum Borrowing Capacity
VERU INC. (VERU) had Line of Credit Facility, Maximum Borrowing Capacity of $10.00 million as of 2015-12-29, per its 10-K filed 2018-01-02.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2018-01-02
- 2015-12-29: Line of Credit Facility, Maximum Borrowing Capacity $10.00M.
- 2015-09-30: Line of Credit Facility, Maximum Borrowing Capacity $2.00M.
- 2014-09-30: Line of Credit Facility, Maximum Borrowing Capacity $2.00M.
- 2014-08-01: Line of Credit Facility, Maximum Borrowing Capacity $2.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2015-12-29 | $10.00M 10-K · filed 2018-01-02 |
| 2015-09-30 | $2.00M 10-K · filed 2015-12-02 |
| 2014-09-30 | $2.00M 10-K · filed 2014-12-02 |
| 2014-08-01 | $2.00M 10-Q · filed 2015-07-30 |
| 2012-08-01 | $2.00M 10-Q · filed 2013-08-01 |
| 2012-06-30 | $2.00M 10-Q · filed 2012-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |